Page last updated: 2024-08-17

spironolactone and clobetasol

spironolactone has been researched along with clobetasol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Aractingi, S; Arnaud, P; Brahimi, N; Crickx, B; Deschamps, L; Duhamel, S; Duval, X; Escoubet, B; Farman, N; Jaisser, F; Laouénan, C; Leclerc-Mercier, S; Maubec, E; Mentré, F; Nguyen, VT; Perret, C; Scheer-Senyarich, I; Steff, M; Tubiana, S; Wackenheim-Jacobs, AC	1

Trials

1 trial(s) available for spironolactone and clobetasol

Article	Year
Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin. The Journal of investigative dermatology, 2015, Volume: 135, Issue:7 Topics: Administration, Topical; Adult; Atrophy; Biopsy, Needle; Clobetasol; Dermoscopy; Double-Blind Method; Epidermis; Female; Glucocorticoids; Healthy Volunteers; Humans; Immunohistochemistry; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Reference Values; Risk Assessment; Spironolactone; Statistics, Nonparametric; Treatment Outcome; Young Adult	2015

Article

Year

Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

The Journal of investigative dermatology, 2015, Volume: 135, Issue:7

Topics: Administration, Topical; Adult; Atrophy; Biopsy, Needle; Clobetasol; Dermoscopy; Double-Blind Method; Epidermis; Female; Glucocorticoids; Healthy Volunteers; Humans; Immunohistochemistry; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Reference Values; Risk Assessment; Spironolactone; Statistics, Nonparametric; Treatment Outcome; Young Adult

2015

Other Studies

1 other study(ies) available for spironolactone and clobetasol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004